Equillium, Inc.EQNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank3
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P3
Near historical low
vs 5Y Ago
-8.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-68.14%
Q2 2025-31.08%
Q1 2025-19.02%
Q4 2024-23.50%
Q3 2024-11.53%
Q2 202410.93%
Q1 20246.10%
Q4 20232.33%
Q3 2023-6.62%
Q2 20233.65%
Q1 20238.76%
Q4 2022-2.80%
Q3 2022-7.56%
Q2 2022-11.85%
Q1 202242.58%
Q4 20218.38%
Q3 202116.37%
Q2 20211.79%
Q1 2021-10.46%
Q4 202055.69%
Q3 20208.35%
Q2 2020-17.28%
Q1 2020-13.64%
Q4 201930.30%
Q3 2019-1.60%
Q2 201913.06%
Q1 201949.29%
Q4 2018106.01%
Q3 2018126.35%
Q2 2018-18.55%
Q1 201837.44%
Q4 2017865.80%
Q3 2017-93.77%
Q2 20170.00%